Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Metabolic Syndrome × Diet × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Motor Activity 12 Breast Neoplasms 9 Polycystic Ovary Syndrome 8 Obesity 8 Colorectal Neoplasms 6 Weight Loss 5 Prostatic Neoplasms 5 Neoplasms 4 Colonic Neoplasms 4 Multiple Endocrine Neoplasia Type 1 3 Pancreatic Neoplasms 2 Overweight 2 Malnutrition 2 Lymphoma, Follicular 2 Lymphoma 2 Lung Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Waldenstrom Macroglobulinemia 1 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Smoking 1 Sexual Dysfunction, Physiological 1 Sarcopenia 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Patient Compliance 1

Interventions

Metformin 7 Magnetic Resonance Spectroscopy 2 Inositol 2 Exercise 2 Ethinyl Estradiol 2 Blood Pressure 2 semaglutide 1 maltodextrin 1 drospirenone and ethinyl estradiol combination 1 drospirenone 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Walking 1 Vascular Stiffness 1 Ultrasonography 1 Triptorelin Pamoate 1 Topiramate 1 Tirzepatide 1 Testosterone 1 Sugars 1 Spironolactone 1 Qsymia 1 Pyruvic Acid 1 Pulse Wave Analysis 1 Preoperative Exercise 1 Pioglitazone 1 Phlebotomy 1 Phentermine 1 Pancreaticoduodenectomy 1 Orchiectomy 1 Naltrexone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03173807 2017-10-06

ProNEST

University of Pittsburgh

Phase NA Withdrawn

Prostatic Neoplasms, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡